HomeInsightsPB

Fredun Pharmaceuticals Ltd PB Ratio

Fredun Pharmaceuticals Ltd PB Ratio

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Nov 13, 2024)

stocks purchased

7.2 K

Stocks Traded

(Nov 13, 2024)

Last Updated on: Nov 14, 2024

Image

Fredun Pharmaceuticals Ltd

NSE: FREDUNPHARMA

PB

2.5

Last updated on: Nov 13, 2024

Key Highlights

  • The P/B Ratio of Fredun Pharmaceuticals Ltd is 2.5 as of 13 Nov 24.
  • The P/B Ratio of Fredun Pharmaceuticals Ltd changed from 6 on March 2022 to 2.8 on March 2024 . This represents a CAGR of -22.43% over 3 years. .

Historical P/B Ratio of Fredun Pharmaceuticals Ltd

No data available

Company Fundamentals for Fredun Pharmaceuticals Ltd

Market Cap

324 Cr

EPS

37.6

P/E Ratio (TTM) *

18.3

P/B Ratio (TTM) *

2.5

Day’s High *

710.0

Day’s Low

680.0

DTE *

1.0

ROE *

13.5

52 Week High

1054.0

52 Week Low

650.0

ROCE *

15.7

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Fredun Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Nov 2024689.85
12 Nov 2024710.05
11 Nov 2024704.45
08 Nov 2024707.8
07 Nov 2024712.9
06 Nov 2024718.7
05 Nov 2024714.95
04 Nov 2024739.55
01 Nov 2024718.75
31 Oct 2024706.2

SWOT Analysis Of Fredun Pharmaceuticals Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Fredun Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Fredun Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/B Ratio

Key Valuation Metric of Fredun Pharmaceuticals Ltd

Share Price

₹690

PB Ratio

The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.


How to calculate Price-to-Book (P/B) Ratio?

The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.


Market capitalization = market value of a stock X no. of outstanding shares


Now, you need to know the net value of an organization's assets.

Book Value of Assets = Total Assets - Total Liabilities of a company


After knowing the value of the above ratios, here is the formula for the P/B Ratio:

P/B Ratio = Market Capitalization/ Book Value of Assets


or you can also use this formula

P/B ratio = Market Price Per Share/ Book Value of Asset Per Share

Historical Market Cap of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Fredun Pharmaceuticals Ltd News Hub

News

Fredun Pharmaceuticals to discuss results

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 26 ...

Read more

16 Oct 202411:59

News

Fredun Pharmaceuticals to hold board meeting

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 3 O...

Read more

27 Sep 202410:45

News

Fredun Pharmaceuticals to hold AGM

Fredun Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will...

Read more

19 Sep 202417:53

News

Fredun Pharmaceuticals AGM scheduled

Fredun Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will...

Read more

19 Sep 202410:08

News

Fredun Pharmaceuticals schedules board meeting

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 ...

Read more

22 Jul 202410:12

News

Board of Fredun Pharmaceuticals recommends final dividend

Fredun Pharmaceuticals announced that the Board of Directors of the Company at its meeting...

Read more

08 May 202409:31

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of Fredun Pharmaceuticals Ltd

What is the PB ratio of Fredun Pharmaceuticals Ltd?

The current PB ratio of Fredun Pharmaceuticals Ltd is 2.48. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Fredun Pharmaceuticals Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Fredun Pharmaceuticals Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Fredun Pharmaceuticals Ltd calculated?

The PB ratio of Fredun Pharmaceuticals Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Fredun Pharmaceuticals Ltd?

A high PB ratio suggests that Fredun Pharmaceuticals Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Fredun Pharmaceuticals Ltd?

A low PB ratio of Fredun Pharmaceuticals Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Fredun Pharmaceuticals Ltd PB Ratio change over time?

Yes, the PB ratio of Fredun Pharmaceuticals Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*